Insulet Corp PODD
Institutional shares held
63.4 Million
467K
calls
639K
puts
Total value of holdings
$17.3B
$127M
calls
$174M
puts
Market Cap
$18.9B
69,403,600
Shares Out.
Institutional ownership
91.32%
# of Institutions
755
We take great care to ensure that the data presented and summarized in this overview for INSULET CORP is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding PODD
View all-
Vanguard Group Inc Valley Forge, PA8.49MShares$2.31 Billion0.04% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.45MShares$2.03 Billion0.42% of portfolio
-
Black Rock Inc. New York, NY6.06MShares$1.65 Billion0.03% of portfolio
-
State Street Corp Boston, MA2.97MShares$810 Million0.03% of portfolio
-
Baillie Gifford & CO2.36MShares$641 Million0.49% of portfolio
-
Geode Capital Management, LLC Boston, MA1.78MShares$484 Million0.04% of portfolio
-
Fil LTD Hamilton, D01.43MShares$390 Million0.38% of portfolio
-
Clearbridge Investments, LLC New York, NY1.41MShares$383 Million0.31% of portfolio
-
Morgan Stanley New York, NY1.3MShares$353 Million0.02% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN1.27MShares$347 Million0.09% of portfolio
Latest Institutional Activity in PODD
Top Purchases
Top Sells
About PODD
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Insider Transactions at PODD
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 27
2025
|
John W. Kapples SVP and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
426
-1.77%
|
$113,742
$267.09 P/Share
|
|
Feb 27
2025
|
Dan Manea SVP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
238
-2.22%
|
$63,546
$267.09 P/Share
|
|
Feb 27
2025
|
Prem Singh SVP, Global Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
207
-3.8%
|
$55,269
$267.09 P/Share
|
|
Feb 27
2025
|
Lauren Budden Group VP, CAO and Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
138
-1.89%
|
$36,846
$267.09 P/Share
|
|
Feb 27
2025
|
Laetitia Cousin SVP, Reg, Quality & Compliance |
SELL
Payment of exercise price or tax liability
|
Direct |
205
-5.05%
|
$54,735
$267.09 P/Share
|
|
Feb 27
2025
|
Mark N Field SVP & Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
368
-2.64%
|
$98,256
$267.09 P/Share
|
|
Feb 27
2025
|
James Hollingshead President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,074
-3.05%
|
$553,758
$267.09 P/Share
|
|
Feb 27
2025
|
Eric Benjamin EVP, CPXO |
SELL
Payment of exercise price or tax liability
|
Direct |
644
-3.81%
|
$171,948
$267.09 P/Share
|
|
Feb 25
2025
|
Dan Manea SVP, Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,406
+11.61%
|
-
|
|
Feb 25
2025
|
Prem Singh SVP, Global Operations |
BUY
Grant, award, or other acquisition
|
Direct |
1,406
+20.5%
|
-
|
|
Feb 25
2025
|
Lauren Budden Group VP, CAO and Controller |
BUY
Grant, award, or other acquisition
|
Direct |
562
+7.16%
|
-
|
|
Feb 25
2025
|
Mark N Field SVP & Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,062
+12.91%
|
-
|
|
Feb 25
2025
|
James Hollingshead President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
7,687
+10.15%
|
-
|
|
Feb 25
2025
|
John W. Kapples SVP and General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
1,781
+6.91%
|
-
|
|
Feb 25
2025
|
Ana Maria Chadwick EVP, CFO & Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
2,577
+13.85%
|
-
|
|
Feb 25
2025
|
Laetitia Cousin SVP, Reg, Quality & Compliance |
BUY
Grant, award, or other acquisition
|
Direct |
960
+19.14%
|
-
|
|
Feb 25
2025
|
Eric Benjamin EVP, CPXO |
BUY
Grant, award, or other acquisition
|
Direct |
2,671
+13.65%
|
-
|
|
Feb 17
2025
|
John W. Kapples SVP and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,536
-6.47%
|
$430,080
$280.56 P/Share
|
|
Feb 17
2025
|
John W. Kapples SVP and General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
4,628
+16.3%
|
-
|
|
Feb 17
2025
|
Dan Manea SVP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
722
-7.21%
|
$202,160
$280.56 P/Share
|
Last 12 Months Summary
Buy / Acquisition
131K
Shares
From
22
Insiders
| Grant, award, or other acquisition | 99.3K shares |
|---|---|
| Bona fide gift | 843 shares |
| Exercise of conversion of derivative security | 31K shares |
| Open market or private purchase | 100 shares |
Sell / Disposition
85.1K
Shares
From
16
Insiders
| Bona fide gift | 843 shares |
|---|---|
| Open market or private sale | 51.2K shares |
| Payment of exercise price or tax liability | 33.1K shares |